Pfizer’s HYMPAVZI Gains FDA Approval for Expanded Hemophilia Care
NEW YORK, USA – June 8, 2026 Pfizer has secured U.S. Food and Drug Administration (FDA) approval for an...
Fast Track designation
Advertisement
GSK to Acquire Nuvalent in $10.6B Lung Cancer Expansion
LONDON, United Kingdom & BOSTON, Massachusetts, USA – June 8, 2026 GSK has announced a definitive agreement to acquire...
Incyte to Acquire Vega Therapeutics for $2 Billion Deal
WILMINGTON, Delaware, USA – June 8, 2026 Incyte Corporation has announced a definitive agreement to acquire Vega Therapeutics, a...
Galmed and Tissue Dynamics Uncover Novel Pathway in Cardiac Fibrosis
REHOVOT and RAMAT-GAN, Israel, June 2, 2026 Galmed Pharmaceuticals and Tissue Dynamics have announced a significant preclinical breakthrough in...
Alife Health Receives FDA Clearance for AI-Powered Embryo Selection Technology
SAN FRANCISCO, May 28, 2026 Alife Health has achieved a major milestone in reproductive medicine with the U.S. Food...
Advertisements
Ansun Biopharma Advances Phase 3 DAS181 Trial Following Positive DMC Review
SAN DIEGO, June 1, 2026 Ansun Biopharma has announced a significant clinical development milestone after an independent Data Monitoring...
Sanofi’s Venglustat Gains FDA Priority Review for GD3
PARIS, France, May 28, 2026 Sanofi has achieved a major regulatory milestone with the U.S. Food and Drug Administration...
Aligos Therapeutics Gains Fast Track for HBV Drug
SOUTH SAN FRANCISCO, Calif., April 14, 2026 Aligos Therapeutics, Inc. has announced encouraging progress in its Phase 2 B-SUPREME...
FDA Clears First-in-Class Vectorized Antibody ALS Trial With VTx-002
Amsterdam, The Netherlands, and Boston, MA — January 8, 2026 — VectorY Therapeutics announced that the U.S. Food and...
MAIA Board Financing Reinforces Confidence in Phase 3 Cancer Drug
CHICAGO, USA | December 24, 2025 — MAIA Biotechnology, a clinical-stage biopharmaceutical company focused on targeted immuno-oncology, announced that...
Advertisement
